Angiogenesis Not Yet Recruiting Phase 2 Trials for Erythropoietin (DB00016)

IndicationStatusPhase
DBCOND0036757 (Angiogenesis)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02603406Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion DeficitsTreatment